ClinicalTrials.Veeva

Menu

Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients

S

Schön Klinik Berchtesgadener Land

Status

Unknown

Conditions

Lung Diseases, Interstitial
Pulmonary Disease, Chronic Obstructive

Study type

Observational

Funder types

Other

Identifiers

NCT04159129
Ampel2019

Details and patient eligibility

About

The aim of this study is to evaluate the effects of a three-week inpatient pulmonary rehabilitation (PR) program on the walking speed in patients with chronic obstructive (COPD) or interstitial lung disease (ILD).

Full description

At most german traffic light crossings, a walking speed of 1,2m/sec is required to cross the road in time. Patients who are unable to cross the road at this speed, expose themselves to an increased level of stress and possibly the risk of accidents. Thus, they are discouraged from participating in an active social life.

An UK study (Nolan et al., Thorax 2018) showed that only 10.7% of the 926 patients with moderate COPD attained a walking speed of 1.2m/sec. As PR plays a key role in the management of chronic lung diseases in order to improve patients´ exercise capacity, the aim of this study was to evaluate the PR effects on the Walking Speed in patients with COPD or ILD. The investigators hypothesize that PR improves the ability to cross the road in the appropriate time.

Enrollment

43 estimated patients

Sex

All

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participation in a pulmonary Rehabilitation program (Schön Klinik BGL)
  • Indication: COPD or ILD
  • COPD; FEV1 <50%
  • ILD: FVC <70%
  • written informed consent

Exclusion criteria

  • non compliance

Trial contacts and locations

1

Loading...

Central trial contact

Klaus Kenn, Prof.; Inga Jarosch, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems